Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications

Parasitology Research

Volumn 115, Issue 5, 2016, Pages 1945-1953

  Gamboa, G V Ullio ^a   Palma, S D ^a   Lifschitz, A ^c   Ballent, M ^c   Lanusse, C ^c   Passirani, C ^b   Benoit, J P ^b   Allemandi, D A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Drug delivery systems; Ivermectin; Lipid nanocapsules; Pharmacokinetic; Tissue distribution

Indexed keywords

IVERMECTIN; LIPID; NANOCAPSULE; NANOCARRIER; ANTIPARASITIC AGENT; DRUG CARRIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD; COMPLEMENT ACTIVATION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; ENCAPSULATION; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; MACROPHAGE; MAXIMUM PLASMA CONCENTRATION; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SUSPENSION; ANIMAL; CHEMISTRY; DRUG ADMINISTRATION ROUTE; METABOLISM; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ANIMALS; ANTIPARASITIC AGENTS; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; INJECTIONS, SUBCUTANEOUS; IVERMECTIN; LIPIDS; MACROPHAGES; NANOCAPSULES; RATS; TISSUE DISTRIBUTION;

EID: 84957551295     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-016-4937-1     Document Type: Article

References (38)

1. Alvinerie M, Sutra JF, Galtier P (1993) Ivermectin in goat milk after subcutaneous injection. Vet Res 24:417–421
2. 188Re-labeled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur J Nucl Med Mol Imaging 33:602–607
3. Basilea L, Passirani C, Huynh NT, Béjaud J, Benoit JP, Puglisi G, Pignatello R (2012) Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative. Int J Pharm 426:231–238
4. Bassissi F, Lespine A, Alvinerie M (2006) Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration. Parasitol Res 3:244–249
5. Chiu SHL, Green ML, Bayliss FP, Eline D, Rosegay A, Meriwether H, Jacob TA (1990) Absorption, tissue distribution, and excretion of tritium-labeled ivermectin in cattle, sheep, and rat. J Agric Food Chem 38:2072–2078
6. De Montigny P, Shim JS, Pivnichny JV (1990) Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent. J Pharm Biomed Anal 8:507–511
7. Demeler J, Van Zeveren AM, Kleinschmidt N, Vercruysse J, Höglund J, Koopmann R, Cabaret J, Claerebout E, Areskog M, von Samson-Himmelstjern G (2009) Monitoring the efficacy of ivermectin and albendazole against gastro intestinal nematodes of cattle in Northern Europe. Vet Parasitol 160:109–115
8. Eraslan G, Kanbur M, Liman BC, Cam Y, Karabacak M, Altinordulu S (2010) Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs. Food Chem Toxicol 48:2181–2185
9. Garcion E, Lamprecht A, Heurtault B, Paillard A, Aubert-Pouessel A, Denizot B, Menei P, Benoît JP (2006) A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5:1710–1722
10. Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York
11. González Canga A, Sahagún Prieto AM, José Diez Liébana M, Martínez NF, Vega MS, Vieitez JJ (2009) The pharmacokinetics and metabolism of ivermectin in domestic animal species. Rev Article Vet J 179:25–37
12. Hennessy DR (1997) Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds. Vet Parasitol 72:367–382
13. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP (2002) A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19:875–880
14. Huynh NT, Passirani C, Saulnier P, Benoit JP (2009) Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 379:201–209
15. Kaplan RM (2004) Drug resistance in nematodes of veterinary importance. A status report. Trend Parasitol 20:477–481
16. Kawashima Y (2006) Nanoparticulate systems for improved drug delivery. Adv Drug Del Rev 47:11–16
17. Kazatchkine MD, Carreno MP (1988) Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 9:30–35
18. Lamprecht A, Benoit JP (2006) Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release 112:208–213
19. Lamprecht A, Saumet JL, Roux J, Benoit JP (2004) Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 278:407–414
20. Lanusse C, Lifschitz A, Virkel G, Alvarez L, Sánchez S, Sutra JF, Galtier P, Alvinerie M (1997) Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J Vet Phamacol Ther 20:91–99
21. Lespine A, Alvinerie M, Sutra JF, Pors I, Chartier C (2005) Influence of the route of administration on efficacy and tissue distribution of ivermectin in goat. Vet Parasitol 128:251–260
22. Lifschitz A, Virkel G, Sallovitz J, Sutra JF, Galtier P, Alvinerie M, Lanusse C (2000) Comparative distribution of ivermectin and doramectin to tissues of parasite location in cattle. Vet Parasitol 87:327–338
23. Lifschitz A, Virkel G, Ballent M, Sallovitz J, Imperiale F, Pis A, Lanusse C (2007) Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations. Vet Parasitol 147:303–310
24. Lo P, Fink DW, Williams JB, Blodinger J (1985) Pharmacokinetics studies of ivermectin: effect of formulation. Vet Res Commun 9:251–268
25. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
26. Mosqueira P, Legrand P, Morgat JL, Vert M, Mysiakine E, Gref R, Devissaguet JP, Barratt G (2001a) Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res 18:1411–1419
27. Mosqueira P, Lifschitz A, Virkel G, Alvarez L, Sánchez S, Sutra JF, Galtier P, Alvinerie M (2001b) Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 22:2967–2979
28. Passirani C, Benoit JP (2005) Complement activation by injectable colloidal drug carriers. Biomat Deliv Target Protein Nucleic Acid 2:187–230
29. Passirani C, Barratt G, Devissaguet JP, Labarre D (1998) Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci 62:775–785
30. Peltier S, Oger JM, Lagarce F, Couet W, Benoit JP (2006) Enhanced oral paclitaxel bioavailability after administration of paclitaxel loaded lipid nanocapsules. Pharm Res 23:1243–1250
31. Pensel PE, Ullio Gamboa G, Fabbri J, Ceballos L, Sanchez Bruni S, Alvarez LI, Allemandi D, Benoit JP, Palma SD, Elissondo MC(2015) Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop 152:185–194
32. Petrak K (2006) Nanotechnology and site-targeted drug delivery. J Biomater Sci Polym 11:1209–1219
33. Scott EW, McKellar QA (1992) The distribution and some pharmacokinetic parameters of ivermectin in pigs. Vet Res Commun 16:139–146
34. Teli MK, Mutalik S, Rajanikant GK (2010) Nanotechnology and nanomedicine: going small means aiming big. Curr Pharm Des 16:1882–1892
35. Tsuchiya S, Goto Y, Okumura H, Nakae S, Konno T, Tada K (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorboldiester. Cancer Res 42:1530–1536
36. Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC, Benoit JP (2006) Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 78:620–628
37. Wicks S, Kaye B, Weatherley AJ, Lewis D, Davison E, Gibson SP, Smith DG (1993) Effect of formulation on the pharmacokinetics and efficacy of doramectin. Vet Parasitol 49:17–26
38. Yates DM, Wolstenholme AJ (2004) An ivermectin-sensitive glutamate-gated chloride channel subunit from Dirofilaria immitis. Int J Parasitol 34:1075–1081